Thyrocare acquires Think Health to enter at-home ECG services
Thyrocare’s acquisition will enable it to gain access to Think Health’s at-home ECG and phlebotomy services footprint across 10 cities, including Ahmedabad, Chennai, Kanpur, and Jaipur.
PharmEasy-backed Thyrocare has bought a 100% stake in Chennai-based diagnostic service provider Think Health in an all-cash deal that enables it to enter the at-home ECG services and insurance categories.
Think Health offers phlebotomy (blood test) and report analysis services, along with para-medical services, including at-home ECG service. The deal will allow Thyrocare access to Think Health’s footprint across 10 cities including Chennai, Jaipur, Kanpur, and Ahmedabad, it said in a statement on Monday.
The listed company shared details of the acquisition with the stock exchanges through a filing on February 1.
The synergy betweenand Think Health Diagnostics is poised to create India's largest home phlebotomy network with over 100 phlebotomists trained to provide ECG services at home in addition to Thyrocare’s existing network of more than 900 blood-collection phlebotomists, the firm noted in the statement.
“With the strategic acquisition of Think Health Diagnostics, we are well-positioned to expand our footprint in pre-policy medical checkups for the insurance segment. This will allow us to give our insurance partners a one-stop solution for blood and ECG testing and further deepen our presence in the Pre Policy Medical Checkup and Annual Health Checkup market,” Rahul Guha, MD and CEO of Thyrocare Technologies, said.
“Our vision is to scale these services nationwide, leveraging our robust at-home service network and spearheading advancements in comprehensive healthcare accessibility for all across India,” Guha added.
Karkavel, CEO and Director of Think Health, added, “Thyrocare’s strategic alignment with Think Health’s home diagnostics expertise is undeniable. Together, we will leverage our extensive network and expertise to create an unparalleled offering, delivering seamless healthcare directly to patients' doorsteps.”
Thyrocare posted an operational revenue of Rs 134.7 crore in the quarter ended December 31, 2023, up 5% from Rs 128 crore in the same period last year.
Profit for the quarter stood at Rs 15.3 crore against Rs 14.7 crore in the year-ago period, a marginal rise hurt by higher expenses.
(The copy was updated to reflect changes made in the lede.)
Edited by Affirunisa Kankudti